Table 1.
Clinical characteristics of the study population. AD: Alzheimer’s disease; MCI: mild cognitive impairment; SCI: subjective cognitive impairment; MMSE: mini mental state examination; BZD: benzodiazepine.
| Characteristics | SCI (n = 22) | MCI (n = 28) | AD (n = 28) |
|---|---|---|---|
| Age (mean ± SD) | 68.9 ± 10.3 | 75.46 ± 9.15 | 80.8 ± 10.5 |
| Female (%) | 81.8% | 67.8% | 67.8% |
| MMSE (mean ± SD) | 28.3 ± 1.6 | 23.8 ± 5.9 | 18.3 ± 6.1 |
| BZD use (%) | 4 (18.2%) | 2 (7.1%) | 8 (28.6%) |
| Antidepressant use (%) | 2 (9.1%) | 4 (14.2%) | 12 (42.8%) |
| Neuroleptic use (%) | 0 | 2 (7.1%) | 5 (17.8%) |
| Hypnotic use (%) | 5 (22.7%) | 5 (17.19%) | 7 (25%) |